Arylsulfatase A, a genetic modifier of Parkinson's disease, is an α-synuclein chaperone.

Mutations in lysosomal genes increase the risk of neurodegenerative diseases, as is the case for Parkinson's disease. Here, we found that pathogenic and protective mutations in arylsulfatase A (ARSA), a gene responsible for metachromatic leukodystrophy, a lysosomal storage disorder, are linked to Parkinson's disease. Plasma ARSA protein levels were changed in Parkinson's disease patients. ARSA deficiency caused increases in α-synuclein aggregation and secretion, and increases in α-synuclein propagation in cells and nematodes. Despite being a lysosomal protein, ARSA directly interacts with α-synuclein in the cytosol. The interaction was more extensive with protective ARSA variant and less with pathogenic ARSA variant than wild-type. ARSA inhibited the in vitro fibrillation of α-synuclein in a dose-dependent manner. Ectopic expression of ARSA reversed the α-synuclein phenotypes in both cell and fly models of synucleinopathy, the effects correlating with the extent of the physical interaction between these molecules. Collectively, these results suggest that ARSA is a genetic modifier of Parkinson's disease pathogenesis, acting as a molecular chaperone for α-synuclein.

[1]  N. Hattori,et al.  COQ2 variants in Parkinson’s disease and multiple system atrophy , 2018, Journal of Neural Transmission.

[2]  E. Masliah,et al.  Exposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril , 2016, Scientific Reports.

[3]  Y. Shim,et al.  Anti-aging treatments slow propagation of synucleinopathy by restoring lysosomal function , 2016, Autophagy.

[4]  K. Wada,et al.  Glucocerebrosidase deficiency accelerates the accumulation of proteinase K-resistant α-synuclein and aggravates neurodegeneration in a Drosophila model of Parkinson's disease. , 2015, Human molecular genetics.

[5]  W. Chung,et al.  Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations. , 2015, Brain : a journal of neurology.

[6]  O. Brüstle,et al.  Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy. , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  Kengo Kinoshita,et al.  Rare variant discovery by deep whole-genome sequencing of 1,070 Japanese individuals , 2015, Nature Communications.

[8]  K. Ohno,et al.  CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study , 2015, The Lancet Neurology.

[9]  E. Masliah,et al.  Glucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein , 2014, Nature Communications.

[10]  Yoav Ben-Shlomo,et al.  Parkinson’s Disease – the Debate on the Clinical Phenomenology, Aetiology, Pathology and Pathogenesis , 2014, Journal of Parkinson's disease.

[11]  He-Jin Lee,et al.  Extracellular α-synuclein—a novel and crucial factor in Lewy body diseases , 2014, Nature Reviews Neurology.

[12]  J. Nutt,et al.  Parkinsonism syndrome in heterozygotes for Niemann–Pick C1 , 2013, Journal of the Neurological Sciences.

[13]  H. Liany,et al.  A rare lysosomal enzyme gene SMPD1 variant (p.R591C) associates with Parkinson's disease , 2013, Neurobiology of Aging.

[14]  Deanna M. Church,et al.  ClinVar: public archive of relationships among sequence variation and human phenotype , 2013, Nucleic Acids Res..

[15]  He-Jin Lee,et al.  Glucocerebrosidase, a new player changing the old rules in Lewy body diseases , 2013, Biological chemistry.

[16]  A. Mirelman,et al.  The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease , 2013, Neurology.

[17]  N. Hattori,et al.  VPS35 mutation in Japanese patients with typical Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[18]  M. Prata,et al.  Mannose-6-phosphate pathway: a review on its role in lysosomal function and dysfunction. , 2012, Molecular genetics and metabolism.

[19]  Dae Hyuk Moon,et al.  Subregional Patterns of Preferential Striatal Dopamine Transporter Loss Differ in Parkinson Disease, Progressive Supranuclear Palsy, and Multiple-System Atrophy , 2012, The Journal of Nuclear Medicine.

[20]  M. Ban,et al.  Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome , 2012, Movement disorders : official journal of the Movement Disorder Society.

[21]  T. Cox,et al.  The cellular pathology of lysosomal diseases , 2012, The Journal of pathology.

[22]  T. Outeiro,et al.  Zooming into protein oligomerization in neurodegeneration using BiFC. , 2010, Trends in biochemical sciences.

[23]  N. Hattori,et al.  No evidence for pathogenic role of GIGYF2 mutation in Parkinson disease in Japanese patients , 2010, Neuroscience Letters.

[24]  Sonja W. Scholz,et al.  Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.

[25]  M. Nalls,et al.  Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. , 2009, The New England journal of medicine.

[26]  P. Taschner,et al.  Caenorhabditis elegans as a model for lysosomal storage disorders. , 2008, Biochimica et biophysica acta.

[27]  Nir Giladi,et al.  Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset , 2008, Neurology.

[28]  Y. Hirayasu,et al.  Neuronal and glial accumulation of α- and β-synucleins in human lipidoses , 2007, Acta Neuropathologica.

[29]  T. Noda,et al.  Dissection of the Autophagosome Maturation Process by a Novel Reporter Protein, Tandem Fluorescent-Tagged LC3 , 2007, Autophagy.

[30]  J. Aharon-Peretz,et al.  Mutations in the glucocerebrosidase gene and Parkinson disease: Phenotype–genotype correlation , 2005, Neurology.

[31]  Peter T. Lansbury,et al.  Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy , 2004, Science.

[32]  J. Allman,et al.  Neuropathology provides clues to the pathophysiology of Gaucher disease. , 2004, Molecular genetics and metabolism.

[33]  He-Jin Lee,et al.  Clearance of α-Synuclein Oligomeric Intermediates via the Lysosomal Degradation Pathway , 2004, The Journal of Neuroscience.

[34]  Jeremy N. Skepper,et al.  α-Synuclein Is Degraded by Both Autophagy and the Proteasome* , 2003, Journal of Biological Chemistry.

[35]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[36]  John Q. Trojanowski,et al.  Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease , 2001, Science.

[37]  Y. Ihara,et al.  Accumulation and Aggregation of Amyloid β-Protein in Late Endosomes of Niemann-Pick Type C Cells* , 2001, The Journal of Biological Chemistry.

[38]  T. Chase,et al.  Degradation of α-Synuclein by Proteasome* , 1999, The Journal of Biological Chemistry.

[39]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[40]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[41]  K. von Figura,et al.  Arylsulfatase A pseudodeficiency: loss of a polyadenylylation signal and N-glycosylation site. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[42]  L. Warren Stimulated secretion of lysosomal enzymes by cells in culture. , 1989, The Journal of biological chemistry.

[43]  W. Gibb,et al.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[44]  R. Brady,et al.  Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease. , 1966, The Journal of clinical investigation.

[45]  N. Hattori,et al.  Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS. , 2013, Parkinsonism & related disorders.

[46]  A. Harris,et al.  Identification of seven novel mutations associated with metachromatic leukodystrophy , 1995, Human mutation.

[47]  A. Allison,et al.  The secretion of lysosomal enzymes. , 1976, Frontiers of biology.